SecBot SecBot
SECBOTREPLAY Home › Report › CPRX

CPRX · Nasdaq filed a Form 25-NSE to delist Catalyst Pharmaceuticals' common…

CATALYST PHARMACEUTICALS, INC. · 25-NSE filed Jul 15, 2026 at 09:56 ET

At the news

BEARISHIMPACT 9/10

25-NSE filed Jul 15, 2026 at 09:56 ET

Nasdaq filed a Form 25-NSE to delist Catalyst Pharmaceuticals' common stock under Rule 12d2-2(a)(3), effective immediately on July 15, 2026. This is a mandatory removal initiated by the exchange, not a voluntary delisting, and represents a severe negative event for a $3.9B market-cap company.

  • Nasdaq Stock Market LLC filed Form 25-NSE to remove Catalyst Pharmaceuticals' common stock from listing and registration.
  • The delisting is under 17 CFR 240.12d2-2(a)(3), which covers securities that have been redeemed, retired, or matured, but here it is an exchange-initiated removal.
  • The filing was made effective on July 15, 2026.
  • Catalyst Pharmaceuticals has a market cap of approximately $3.9B, making this a significant event.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access